⌘K

Login Start Free

Home/Insiders/Wolf Myles

WM

SEC Insider//CIK 0001808317

Wolf Myles

CIK 00018083171 companyCAMBRIDGE, MA

Transactions

11

Companies

1

Filings

6

CIK

0001808317

Recent Transactions

11 trades

Award
Akebia Therapeutics, Inc.$AKBA
Stock Option (Right to buy)
2025-06-10+53,600→ 53,600 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2025-06-10+35,700→ 133,381 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2024-06-06+30,000→ 97,681 total
Award
Akebia Therapeutics, Inc.$AKBA
Stock Option (Right to buy)
2024-06-06+45,000→ 45,000 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2023-06-06+30,000→ 67,681 total
Award
Akebia Therapeutics, Inc.$AKBA
Stock Option (Right to buy)
2023-06-06+45,000→ 45,000 total
Award
Akebia Therapeutics, Inc.$AKBA
Stock Option (Right to buy)
2022-06-08+20,100→ 20,100 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2022-06-08+13,700→ 37,681 total
Award
Akebia Therapeutics, Inc.$AKBA
Stock Option (Right to buy)
2021-06-02+20,100→ 20,100 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2021-06-02+13,700→ 23,981 total
Award
Akebia Therapeutics, Inc.$AKBA
Stock Option (Right to buy)
2020-04-06+80,200→ 80,200 total

Companies

1

Akebia Therapeutics, Inc.
Director
$AKBA

Recent Filings

6

Address

C/O AKEBIA THERAPEUTICS, INC. 245 FIRST ST.

CAMBRIDGE, MA, 02142

View on SEC.gov